HealthFinSMEsabout 2 hours ago
Dren Bio Raises $350M for Therapeutics
1 min read
Dren Bio, a San Carlos biotechnology firm, raised $350M in private financing on 30/10/2026. The round was co-led by Juvia Group and Lightspeed Venture Partners. Funds will support clinical development and the planned commercial launch of lead investigational therapy dibotatug (DR-01) for lymphoma and leukemia indications.
Level
Hype check
Tap to vote and see what everyone thinks.
